Hospitalist Medicine Case and Commentary Sep 2020 How Should Clinicians’ Performance Be Assessed When Health Care Organizations Implement Behavioral Architecture That Generates Negative Consequences? Safiya Richardson, MD, MPH Interventions’ influences on decision making situate clinician performance evaluations in key ways. AMA J Ethics. 2020;22(9):E760-766. doi: 10.1001/amajethics.2020.760. Videocast May 2020 Ethics Talk: Advance Care Planning and End-of-life Care in the COVID Era Dr Helen Chapple talks about eliciting and honoring patients’ health care preferences during the COVID-19 pandemic. Art of Medicine Apr 2020 Who’s in the Hospital Lobby? Katelyn Norman, MD This painting depicts a solitary physician after hours in an empty hospital lobby and is a tribute to such spaces in health care. AMA J Ethics. 2020;22(4):E342-343. doi: 10.1001/amajethics.2020.342. Medicine and Society Mar 2020 How Should We Judge Whether and When Mission Statements Are Ethically Deployed? Kellie E. Schueler and Debra B. Stulberg, MD Mission statements offer limited benefit when patients do not have meaningful choices about where to seek care and can be misused. AMA J Ethics. 2020;22(3):E239-247. doi: 10.1001/amajethics.2020.239. Case and Commentary Oct 2019 How Should Clinical Ethics Consultants Support Parents’ Decision Making? Katherine J. Feder, MS and Janice I. Firn, PhD, LMSW Rather than relying on decision aids, values-based approaches to decision making illuminate a plurality of possible right actions. AMA J Ethics. 2019;21(10):E831-837. doi: 10.1001/amajethics.2019.831. Letter to the Editor Oct 2019 Response to “Will We Code for Default ECMO?”: Clarifying the Scope of Do-Not-ECMO Orders Jacob A. Blythe, MA, Sarah E. Wieten, PhD, and Jason N. Batten, MD, MA The authors further consider the merits of preventing ECMO from becoming a default treatment. AMA J Ethics. 2019;21(10):E926-929. doi: 10.1001/amajethics.2019.926. Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575. Case and Commentary Jul 2019 How Should Clinicians Navigate Decision Making for Unrepresented Patients? Timothy M. Dempsey, MD, MPH and Erin Sullivan DeMartino, MD A deliberative approach to responding to needs and vulnerabilities of unrepresented patients can help make the most of having too little information. AMA J Ethics. 2019;21(7):E559-565. doi: 10.1001/amajethics.2019.559. Case and Commentary Jul 2019 Should Aggregate Patient Preference Data Be Used to Make Decisions on Behalf of Unrepresented Patients? Nathaniel Sharadin, PhD, MA Ethical and practical problems with preference modeling can undermine how reliably predictors can be used in high-stakes decisions. AMA J Ethics. 2019;21(7):E566-574. doi: 10.1001/amajethics.2019.566. Case and Commentary May 2019 How Should ECMO Initiation and Withdrawal Decisions Be Shared? Carolina Jaramillo and Nicholas Braus, MD Case analysis illuminates strategies clinicians can use to reconcile competing duties to patients on ECMO. AMA J Ethics. 2019;21(5):E387-393. doi: 10.1001/amajethics.2019.387. Pagination First page « First Previous page ‹‹ Prev … Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Page 11 Page 12 Page 13 … Next page ›› Next Last page Last »
Case and Commentary Sep 2020 How Should Clinicians’ Performance Be Assessed When Health Care Organizations Implement Behavioral Architecture That Generates Negative Consequences? Safiya Richardson, MD, MPH Interventions’ influences on decision making situate clinician performance evaluations in key ways. AMA J Ethics. 2020;22(9):E760-766. doi: 10.1001/amajethics.2020.760.
Videocast May 2020 Ethics Talk: Advance Care Planning and End-of-life Care in the COVID Era Dr Helen Chapple talks about eliciting and honoring patients’ health care preferences during the COVID-19 pandemic.
Art of Medicine Apr 2020 Who’s in the Hospital Lobby? Katelyn Norman, MD This painting depicts a solitary physician after hours in an empty hospital lobby and is a tribute to such spaces in health care. AMA J Ethics. 2020;22(4):E342-343. doi: 10.1001/amajethics.2020.342.
Medicine and Society Mar 2020 How Should We Judge Whether and When Mission Statements Are Ethically Deployed? Kellie E. Schueler and Debra B. Stulberg, MD Mission statements offer limited benefit when patients do not have meaningful choices about where to seek care and can be misused. AMA J Ethics. 2020;22(3):E239-247. doi: 10.1001/amajethics.2020.239.
Case and Commentary Oct 2019 How Should Clinical Ethics Consultants Support Parents’ Decision Making? Katherine J. Feder, MS and Janice I. Firn, PhD, LMSW Rather than relying on decision aids, values-based approaches to decision making illuminate a plurality of possible right actions. AMA J Ethics. 2019;21(10):E831-837. doi: 10.1001/amajethics.2019.831.
Letter to the Editor Oct 2019 Response to “Will We Code for Default ECMO?”: Clarifying the Scope of Do-Not-ECMO Orders Jacob A. Blythe, MA, Sarah E. Wieten, PhD, and Jason N. Batten, MD, MA The authors further consider the merits of preventing ECMO from becoming a default treatment. AMA J Ethics. 2019;21(10):E926-929. doi: 10.1001/amajethics.2019.926.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.
Case and Commentary Jul 2019 How Should Clinicians Navigate Decision Making for Unrepresented Patients? Timothy M. Dempsey, MD, MPH and Erin Sullivan DeMartino, MD A deliberative approach to responding to needs and vulnerabilities of unrepresented patients can help make the most of having too little information. AMA J Ethics. 2019;21(7):E559-565. doi: 10.1001/amajethics.2019.559.
Case and Commentary Jul 2019 Should Aggregate Patient Preference Data Be Used to Make Decisions on Behalf of Unrepresented Patients? Nathaniel Sharadin, PhD, MA Ethical and practical problems with preference modeling can undermine how reliably predictors can be used in high-stakes decisions. AMA J Ethics. 2019;21(7):E566-574. doi: 10.1001/amajethics.2019.566.
Case and Commentary May 2019 How Should ECMO Initiation and Withdrawal Decisions Be Shared? Carolina Jaramillo and Nicholas Braus, MD Case analysis illuminates strategies clinicians can use to reconcile competing duties to patients on ECMO. AMA J Ethics. 2019;21(5):E387-393. doi: 10.1001/amajethics.2019.387.